SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending as escalating geopolitical tensions, specifically potential US tariffs on European economies related to Greenland and a 'Board of Peace' initiative, spark significant market uncertainty. Community discussions are rife with expectations of a market dip, though many anticipate a swift 'buy the dip' recovery, recalling past instances of market resilience to tariff-related volatility.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is generating significant buzz due to Elon Musk's recent announcements regarding advanced AI chip development and ambitions to scale production with a "TeraFab." However, community sentiment is sharply polarized, with many bears citing concerns over declining sales, fierce global EV competition, and looming Q4 earnings, while bulls remain steadfast on the company's long-term vision in AI and robotics. The backdrop of global trade tensions and competition, notably Chinese EVs entering new markets, amplifies the debate around Tesla's immediate outlook.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending due to escalating U.S.-EU tariff tensions over Greenland, which has triggered a broad risk-off sentiment across the cryptocurrency market. This geopolitical uncertainty has led to substantial long liquidations, sparking community debate about Bitcoin's reliability as a safe haven asset, with some strategizing potential further declines and others viewing current levels as a buying opportunity.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and urging fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as investors eagerly await its upcoming earnings report, with community sentiment sharply divided on its potential impact. Speculation surrounding a significant acquisition of Warner Bros. Discovery assets is a key talking point, alongside recent bond purchases by President Trump, further fueling debate on the stock's immediate future. Many bulls anticipate a strong rebound given oversold conditions, while bears caution about continued downside and the financial implications of the potential deal.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending following recent international approvals for its cancer immunotherapies, notably in Saudi Arabia for lung cancer, alongside updated positive clinical study results. The community is enthusiastically discussing the potential of Anktiva to revolutionize cancer treatment and is vocal about perceived US FDA delays, which is fueling significant speculation around a short squeeze. Investors are expressing strong optimism regarding Dr. Soon-Shiong's strategic vision and the company's considerable growth trajectory.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst widespread discussion surrounding former President Trump's controversial geopolitical moves, specifically his asserted interest in Greenland and proposed tariffs on European allies, which many observers link to a past Nobel Peace Prize snub. Community perspectives are sharply divided, with intense debate on the potential market implications of these actions, reflecting broader concerns about global stability and U.S. foreign policy.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to heightened geopolitical interest surrounding Greenland's critical mineral resources, driven by former President Trump's strong advocacy for US acquisition or strategic involvement. The community is actively discussing the potential for a transformative deal that would secure vital rare earth supplies, alongside the company's recent joint venture for processing. This strategic exposure is generating significant market buzz, with many anticipating substantial future gains ahead of its upcoming business update call.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept Inc. (VERO) is trending due to a single entity's acquisition of a significant 91% stake, which bulls are interpreting as a virtually 'locked' float that neutralizes short-selling pressure. This unprecedented ownership structure has fueled intense speculation among investors, with many anticipating an extraordinary price surge and others warning of a pump-and-dump scenario, citing the majority shareholder's intent to potentially delist the company. Community discussion is highly polarized, drawing comparisons to past volatile, low-float runners.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is experiencing significant volatility as the community intensely debates Bitcoin's near-term price trajectory. Bears are anticipating further downside if key BTC support levels fail, citing potential head-and-shoulders patterns, while bulls remain steadfast, highlighting the company's long-term Bitcoin accumulation strategy and recent institutional investment as catalysts for future growth.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sumitomo Mitsui Trust Group Inc. Sells 701,887 Shares of Recursion Pharmaceuticals, Inc. $RXRX

Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Free Report) by 8.6% during the third quarter, according to the company in its most...

Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note

Recursion Pharmaceuticals (RXRX) closed at $4.65 in the latest trading session, marking a -4.12% move from the prior day.

Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know

Recursion Pharmaceuticals (RXRX) closed at $4.7 in the latest trading session, marking a -3.29% move from the prior day.

Bank Pictet & Cie Europe AG Acquires Shares of 1,630,000 Recursion Pharmaceuticals, Inc. $RXRX

Bank Pictet & Cie Europe AG bought a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Free Report) in the third quarter, according to the company in its most recent 13F filing...

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Key PointsRecursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry...

Insider Selling: Recursion Pharmaceuticals (NASDAQ:RXRX) CFO Sells 21,383 Shares of Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) CFO Ben Taylor sold 21,383 shares of the firm's stock in a transaction that occurred on Monday, December 29th. The stock was sold at an...

Recursion Pharmaceuticals (NASDAQ:RXRX) CFO Ben Taylor Sells 21,383 Shares

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) CFO Ben Taylor sold 21,383 shares of the company's stock in a transaction that occurred on Monday, December 29th. The stock was sold at...

Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Sells $548,617.23 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) insider Najat Khan sold 124,403 shares of the company's stock in a transaction on Monday, December 22nd. The stock was sold at an...

Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Najat Khan Sells 124,403 Shares

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) insider Najat Khan sold 124,403 shares of the business's stock in a transaction on Monday, December 22nd. The stock was sold at an...

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Current Price	$4.67
Prev Close	$4.64
Open	$4.65
Dividend Yield	0.00%
50-Day Moving Average	$4.47
Beta	2.62
Avg. Volume	23.08M
PE Ratio	-2.58

52-Week High	$12.36
52-Week Low	$3.79
Market Capitalization	$2.43B
EPS (Annual)	-$1.69
Price to Book	2.19
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

RXRX
Recursion Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RXRX News

RXRXRecursion Pharmaceuticals Inc